US · AVAH · MEDICAL - CARE FACILITIES
Aveanna Healthcare Holdings Inc. (AVAH) intrinsic value and stock valuation
$11.01as of 2026-11-21 · Mkt cap 2.07B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Aveanna Healthcare Holdings Inc. DCF and intrinsic value
InvestorsCraft values AVAH with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AVAH’s statements →
Aveanna Healthcare Holdings Inc. Graham Number
Graham Number: $4.88d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2018–2026, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- LifeStance Health Group, Inc. (LFST) $13.82
- Brookdale Senior Living Inc. (BKD) $8.86
- Acadia Healthcare Company, Inc. (ACHC) $34.60
- Addus HomeCare Corporation (ADUS) $122.50
- Pediatrix Medical Group, Inc. (MD) $30.22
- LeMaitre Vascular, Inc. (LMAT) $73.61
- Astrana Health, Inc. (ASTH) $28.90
- Ardent Health Inc. (ARDT) $15.08
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.9B | $1.79B | $1.68B |
| Operating income | $265.4M | $139.8M | $8.07M | -$-642.28M | -$-36.11M |
| Net income | $225M | -$-10.93M | -$-134.52M | -$-662.03M | -$-117.04M |
| EPSd | $1.05M | -$-56.66K | -$-708.15K | -$-3.57M | -$-633.57K |
| Operating cash flow | $122.2M | $32.6M | $22.7M | -$-48.4M | — |
| Capital expenditure | -$-7.45M | -$-6.32M | -$-6.12M | -$-12.01M | — |
| Free cash flow | $114.8M | $26.3M | $16.6M | -$-60.41M | — |
| Total assets | $2.03B | $1.66B | $1.61B | $1.71B | — |
| Total debt | $1.51B | $1.5B | $1.5B | $1.36B | — |
| Net debt | $1.32B | $1.42B | $1.46B | $1.34B | — |
| Total equity | $194.5M | -$-122.09M | -$-127.44M | -$-4.17M | — |
| Cash and short-term investments | $193.3M | $84.3M | $43.9M | $19.2M | — |
Income statement
| 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.9B | $1.79B | $1.68B |
| Cost of revenue | $1.63B | $1.39B | $1.3B | $1.23B | $1.14B |
| Gross profit | $805.2M | $635.5M | $595.4M | $553.2M | $542.4M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling, general and administrative expenses | $526.7M | $470.5M | $464.7M | $484M | $419.6M |
| Other expenses | $13M | $25.3M | $122.6M | $711.6M | $158.9M |
| Operating expenses | $539.8M | $495.8M | $587.4M | $1.2B | $578.5M |
| Cost and expenses | $2.17B | $1.88B | $1.89B | $2.43B | $1.71B |
| Interest income | $2.83M | $500K | $330K | $680K | $250K |
| Interest expense | $140.1M | $156.6M | $153.3M | $107.7M | $68.9M |
| Depreciation and amortization | $23.8M | $31.2M | $30.1M | $38.8M | $35.4M |
| Ebitda | $274.6M | $187.4M | $39.2M | -$-525.06M | -$-17.95M |
| Operating income | $265.4M | $139.8M | $8.07M | -$-642.28M | -$-36.11M |
| Total other income/expenses, net | -$-158.43M | -$-134.72M | -$-147.07M | -$-21.54M | -$-77.47M |
| Income before tax | $107M | $5.07M | -$-139M | -$-663.81M | -$-113.58M |
| Income tax expense | -$-118.09M | $16M | -$-4.47M | -$-1.78M | $3.47M |
| Net income | $225M | -$-10.93M | -$-134.52M | -$-662.03M | -$-117.04M |
| Weighted average shares outstanding | $203.5M | $192.9M | $190M | $185.6M | $184.7M |
| Weighted average diluted shares outstanding | $215M | $192.9M | $190M | $185.6M | $184.7M |
Balance sheet
| 2026 | 2024 | 2023 | 2022 | 2020 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $193.3M | $84.3M | $43.9M | $19.2M | $137.3M |
| Net receivables | $313.4M | $277.7M | $245.8M | $225.6M | $180.9M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current assets | $560.2M | $392.7M | $314.9M | $269.8M | $340.6M |
| Property, plant and equipment, net | $55.7M | $58.7M | $70.1M | $77.4M | $78.9M |
| Goodwill and intangible assets | $1.21B | $1.14B | $1.15B | $1.26B | $1.39B |
| Long-term investments | $37.5M | $60.6M | $74.8M | $0.00 | $0.00 |
| Total non-current assets | $1.47B | $1.27B | $1.3B | $1.44B | $1.5B |
| Total assets | $2.03B | $1.66B | $1.61B | $1.71B | $1.84B |
| Accounts payable | $32M | $36.4M | $30.1M | $44.6M | $56.7M |
| Short-term debt | $200.4M | $198.6M | $183M | $28.5M | $24.7M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $29.4M |
| Total current liabilities | $424.5M | $402.2M | $354.8M | $326.5M | $260.4M |
| Long-term debt | $1.31B | $1.3B | $1.32B | $1.33B | $1.2B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $1.41B | $1.38B | $1.39B | $1.39B | $1.32B |
| Capital lease obligations | $43.4M | $47.2M | $54.7M | $58.9M | $52.1M |
| Total liabilities | $1.83B | $1.79B | $1.74B | $1.72B | $1.58B |
| Common stock | $2.11M | $1.93M | $1.91M | $1.89M | $1.42M |
| Retained earnings | -$-1.16B | -$-1.38B | -$-1.37B | -$-1.24B | -$-457.63M |
| Accumulated other comprehensive income (loss) | $0.00 | $1.46M | $2.13M | $0.00 | $0.00 |
| Total equity | $194.5M | -$-122.09M | -$-127.44M | -$-4.17M | $267.2M |
| Total investments | $37.5M | $60.6M | $74.8M | $0.00 | $0.00 |
| Total debt | $1.51B | $1.5B | $1.5B | $1.36B | $1.23B |
| Net debt | $1.32B | $1.42B | $1.46B | $1.34B | $1.09B |
Cash flow statement
| 2026 | 2024 | 2023 | 2022 | 2020 | |
|---|---|---|---|---|---|
| Net income | $225M | -$-10.93M | -$-134.52M | -$-662.03M | -$-57.05M |
| Depreciation and amortization | $28.2M | $31.2M | $30.1M | $38.8M | $30.2M |
| Stock-based compensation | $0.00 | $17.5M | $13.2M | $15.9M | $3.27M |
| Change in working capital | -$-52.66M | -$-29.97M | -$-23.4M | -$-42.22M | $56.5M |
| Accounts receivable | -$-30.22M | -$-28.64M | -$-15.32M | -$-3.23M | $8.56M |
| Inventory | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Accounts payable | -$-6.23M | $6.45M | -$-13.92M | -$-3.92M | -$-6.81M |
| Net cash provided by operating activities | $122.2M | $32.6M | $22.7M | -$-48.4M | $116.6M |
| Investments in property, plant and equipment | -$-7.45M | -$-6.32M | -$-6.12M | -$-12.01M | -$-15.24M |
| Acquisitions, net | -$-14.85M | $0.00 | $0.00 | -$-1.55M | -$-178.31M |
| Net cash used for investing activities | -$-22.3M | -$-6.32M | -$-8.79M | -$-25.29M | -$-193.54M |
| Common stock issued | $6.52M | $3.09M | $940K | $4.01M | $50M |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for financing activities | $9.03M | $14M | $10.9M | $62.4M | $210.9M |
| Net change in cash | $109M | $40.4M | $24.7M | -$-11.27M | $134M |
| Cash at end of period | $193.3M | $84.3M | $43.9M | $19.2M | $137.3M |
| Operating cash flow | $122.2M | $32.6M | $22.7M | -$-48.4M | $116.6M |
| Capital expenditure | -$-7.45M | -$-6.32M | -$-6.12M | -$-12.01M | -$-15.24M |
| Free cash flow | $114.8M | $26.3M | $16.6M | -$-60.41M | $101.4M |
Line items
Line items
Line items
About Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc. operates as a diverse platform for home-based care services throughout the United States. The company delivers a range of critical offerings, including private duty nursing (PDN), adult home health and hospice care, in-home pediatric therapy, and enteral nutrition services. Its patient-centered approach allows individuals to receive essential medical care within their own homes, effectively reducing the need for costly institutional settings such as hospitals. The company's operations are structured into three key segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment provides specialized private duty nursing, which includes skilled nursing care for medically fragile children at home, nursing support in school environments, and services at pediatric day healthcare centers. This segment also offers employer-of-record support, personal care services, and pediatric therapy (physical, occupational, and speech) provided both in clinics and patients' residences. The HHH segment focuses on home health services, encompassing in-home skilled nursing, physical, occupational, and speech therapy, as well as medical social work and aide assistance. Furthermore, it delivers hospice services, offering compassionate care to patients and their families when life-limiting illnesses no longer respond to curative treatments. The MS segment supplies enteral nutrition products and other vital medical supplies to adults and children, distributed on either a scheduled or as-needed basis. Founded in 2016, Aveanna Healthcare Holdings Inc. is headquartered in Atlanta, Georgia.
- CEO
- Jeffrey S. Shaner
- Employees
- 35.5K
- Beta
- 1.89
Explore
Frequently asked questions
What is the intrinsic value of Aveanna Healthcare Holdings Inc. (AVAH)?
InvestorsCraft does not currently publish an intrinsic value for AVAH. How the IC value is calculated.
Is AVAH undervalued?
InvestorsCraft does not publish an undervaluation signal for AVAH at this time.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.